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Because of the interest in Griseofulvin in respect to its fu ngicidal properties, it was felt that it would be useful to undertake a very limited preliminary trial in order to ascertain whether Griseofulvin has any effect on the M. leprae. Early workers, particularly REEN STIERNA, was of the opinion that M. leprae was originally a soil fu ngus and, over the centuries, adapted itself to human tissues. It seems, therefore, to be a reasonable hypothesis that Griseofulvin might have an effect on the M. /eprae.
The following two cases under a short trial with Griseofulvin are reported : (It should be noted that while the second biopsy report showed marked morphological change in the bacilli, the third biopsy showed no signs of such changes, and that the number of bacilli, if any, had increase for the note is that 'there are enormous numbers of acid-fast bacilli and most of the macrophages were crammed with bacil li'. J n these circumstances it was fe lt that Griseofulvin was having no effect on the disease and, therefore, the treatment was discontinued.)
Merama. Hospital Case No. 6954. Body weight 120 lb. There is a scattered infiltration underneath the epidermis with a relatively clear sub-epidermal zone. In the dermis proper, the infiltration is much more intense, especially in the region of neuro-vascular bundles. The infiltration generally is lymphocytic and histiocytic ; the lymphocytic response, however, is not focalised in any particular pattern. Nerves are most easily recognised because of the intense infiltration, but when they are seen they are not involved. F.F. Stain. Scattered acid-fast bacilli seen in moderately numerous numbers amidst the cellular infiltrate. Diagnosis. A moderately early lepromatous case.
Patient continued treatment from 17/5/61 through to 5/9/61-a period of approximately fo ur months. At the end of this period, that is on 5.9.61, a further biopsy was performed following in the histopathological report. Biopsy No.2 takell 5.9.61. Lab. No. 4587 H.E. Section. There is an infiltration underneath the epidermis extending the whole length of the superficial part of the corium leaving a relatively clear sub-epidermal zone. The infiltrate is moderate to gross in intensity, and consists chiefly of histiocytes and lymphocytes: there is no evidence of foamy cell change, neither is there any evidence of the focal distribution of the lymphocytic response. Because the biopsy is too shallow, nerves cannot be readily seen: I think I can see an occasional nerve twig, which is uninvolved but apart from this I cannot recognise any nerve tissue. F.F. Stain. Moderately large numbers of acid-fast bacilli seen throughout the granulomatous infiltration showing marked morphological change. Diagnosis. The general impression is that this is a moderately early lepromatous case which, because of the granularity of the acid-fast bacilli would indicate that the case is under the influence of therapy.
General Conclusion
Although during this period, the M. /eprae showed considerable morphological change, clinically there was no marked improvement, and further, owing to the fact that when the patient was admitted it was noticed that the M. /eprae showed morphological change. It was thought that this finding was hardly significant. The morphological change seen in the bacilli in the first biopsy possibly indicated that she had received Sulphone therapy elsewhere, for this is regularly available, or it may simply be that the M. /eprae showed a significant change in morphology, because it is known that even when a case is not under therapy M. leprae can show morphological change, fo r in the natural course of the disease, there are periods of quiescence and activity. The conclusion, therefore, was that this patient has shown no significant improvement in the fo ur months she was under Griseofulvin therapy, therefore it was not considered justified to continue her treatment. She was put on standard D.D.S. therapy and has since shown quite marked improvement.
Summary
Two cases of lepromatous leprosy. One a moderately advanced lepromatous case, the other a moderately early diffuse lepromatous case, were given Griseofulvin therapy, and in neither instance was there sufficient improvement or indication of sufficient improvement to justify the continuation of the remedy, and therefore, it must be concluded that Griseofulvin has little or no action on the M. leprae, and therefore, it is not advised as a treatment fo r the disease.
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